Émilie Poirion1, Julien Savatovsky1, Jessica Guillaume2, and Mathieu Santin3,4,5
1Imaging department, Rothschild Foundation Hospital, Paris, France, 2Research clinical department, Rothschild Foundation Hospital, Paris, France, 3Institut du Cerveau (ICM) - Paris Brain Institute, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Paris, France, 4Center for NeuroImaging Research (CENIR), Paris, France, 5MDS Research International, La Rochette, France
Synopsis
Keywords: Quantitative Imaging, Quantitative Susceptibility mapping
Despite
the characterization of in-vivo biomarkers of MS pathophysiology, there
is still a gap between histological knowledges and morphological MRI as it is
performed in clinical practice. New MRI advanced techniques, such as quantitative
susceptibility mapping (QSM) might help to better describe the disease, but long
acquisition times are limiting their uses. Adding acceleration techniques can
reduce this time. However, there is no current evidence about their impact on
QSM values. Thus, we added four QSM sequences to our clinical protocol of MS
follow-up, varying the acceleration factor from classical SENSE (2*2) to high
compressed-sense (6, 9, and 12).
INTRODUCTION
Pathophysiology of Multiple Sclerosis (MS) has
been widely described with histology [1],[2] and numerous efforts have been made
for the characterization of in-vivo biomarkers using MRI or nuclear
medicine studies [3],[4]. Morphological MRI as it is
performed in clinical practice fails to detect and quantify MS pathophysiology mechanisms,
such as myelination and inflammation. MRI advanced techniques has the potential
to assess iron content retained by activated microglia/macrophages during
inflammation, such as quantitative susceptibility mapping (QSM) [5]. Nonetheless, long acquisition
times and complex post-processing are limiting the possibilities of
incorporating QSM into clinical protocols.
Several acceleration techniques may be added to
susceptibility sequences. Among those, compressed-sense (CS) has the potential
to allow a millimetric isotropic acquisition to be done in a short duration
that would be usable in clinical protocols. However, the reproducibility of QSM
data based on MRI parameters has been poorly described, in particular regarding
acceleration factor.
In this project, we aimed to investigate the
impact of CS on QSM data compared to SENSE, a more conservative and widely used
acceleration factor.METHODS
Twenty-four MS patients underwent a 3T MRI scan
(Ingenia, Philips Healthcare) as part of their clinical routine, including a
set of QSM data with variable level of CS (6, 9 and 12) (Figure 1). Clinical protocol
included T1 EG, FLAIR and susceptibility imaging with SENSE 2*2. Parameters of
the four QSM sequences are detailed below.
QSM raw data were acquired using a 3D-FFE sequence
with the following parameters: FOV: 240*240*176 mm3, Voxel size =
1.0*1.2*1.0 mm3 reconstructed to 1.0*1.0*1.0 mm3. Elliptical
scan, TR = 41 ms, TEs = 3.1 ms to 36.1 ms with a ΔTE of 3 ms,
Bandwidth per pixel = 913.7 Hz. Acceleration factor used were SENSE 2*2,
CS-SENSE 6, CS-SENSE 9 and CS-SENCE 12, leading to a total scan time of
respectively: 4 min 43 s, 3 min 20 s, 2 min 54 s and 1 min 40 s. For susceptibility
maps reconstruction, the local field map was calculated by non-linear fitting
the complex gradient echo signal over echo times, then background field removal
was performed using the pre-conditioned Laplacian boundary value method (LBV)
and the inversion was solved using the L1-MEDI method.
T2 hyperintense lesions were segmented on FLAIR
with reference to T1, and corresponding lesion masks were aligned to the T1 scan using ANTS. After performing a lesion-filling, T1 scans were segmented
using FIRST. Thus, we obtained the following region-of-interests (ROI): putamen,
caudate nucleus, and T2 hyperintense lesions. We used putamen and caudate as
reference ROIs as there QSM signal is well characterized.
For each ROI, concordance between each CS
factor and SENSE was evaluated using a Bland-Altman plot and an intraclass
correlation with 95% confidence interval.RESULTS
CS-SENSE technique showed a promising ability
to reduce scan time, ranging from 4 min 43 for the SENSE acquisition to 1 min
40 s for the highest CS factor. This major reduction of the scan time came with
a stable intraclass correlation across each reference ROIs, as well as confidence
interval suggestive of a high reproducibility between techniques (Table 1).
We found similar results for T2 hyperintense
lesions showing intraclass correlation classified as excellent.DISCUSSION
In this project, we demonstrated the stability
of the QSM signal, varying the acceleration factor starting from common factor
used in clinic to high factors to drastically reduce the scan duration.
These results are encouraging for a widely used of this technique in clinical
practice, especially for MS patients and the WM lesions characterization. However,
we still need to demonstrate that none of the anatomical information from the
magnitude images used in image reading is lost with the acceleration.
Moreover, based on this results,
reproducibility of other reconstruction technique such as the 𝜒-separation [6], which might help to differentiate
iron/myelin contribution should be investigated and later translate into clinical
practice.Acknowledgements
EP, JS, JG, MS have nothing to disclose regarding this work.References
[1] H. Lassmann, « Pathology and
disease mechanisms in different stages of multiple sclerosis », J.
Neurol. Sci., vol. 333, no 1, p. 1‑4, oct. 2013, doi:
10.1016/j.jns.2013.05.010.
[2] H. Lassmann,
« Pathogenic Mechanisms Associated With Different Clinical Courses of
Multiple Sclerosis », Front. Immunol., vol. 9, p. 3116, 2019, doi:
10.3389/fimmu.2018.03116.
[3] B.
Bodini et al., « Individual mapping of innate immune cell
activation is a candidate marker of patient-specific trajectories of disability
worsening in Multiple Sclerosis », J. Nucl. Med., janv. 2020, doi:
10.2967/jnumed.119.231340.
[4] C.
Louapre, B. Bodini, C. Lubetzki, L. Freeman, et B. Stankoff, « Imaging
markers of multiple sclerosis prognosis », Curr. Opin. Neurol.,
vol. 30, no 3, p. 231‑236, 2017, doi:
10.1097/WCO.0000000000000456.
[5] K.
Deh et al., « Magnetic susceptibility increases as diamagnetic
molecules breakdown: Myelin digestion during multiple sclerosis lesion formation
contributes to increase on QSM: Myelin Breakdown in MS Lesion Formation »,
J. Magn. Reson. Imaging, vol. 48, no 5, p. 1281‑1287,
nov. 2018, doi: 10.1002/jmri.25997.
[6] H.-G.
Shin et al., « χ-separation: Magnetic susceptibility source
separation toward iron and myelin mapping in the brain », NeuroImage,
vol. 240, p. 118371, oct. 2021, doi: 10.1016/j.neuroimage.2021.118371.